| scholarly article | Q13442814 |
| P50 | author | Jiro Mitobe | Q42240608 |
| Nobuo Koizumi | Q37839682 | ||
| P2093 | author name string | Hemanta Koley | |
| Soma Mitra | |||
| Ken Shimuta | |||
| Dhrubajyoti Nag | |||
| Ritam Sinha | |||
| Noriko Saito | |||
| P2860 | cites work | Immunity to experimental keratoconjunctivitis shigellosa in guinea pigs | Q71192978 |
| A study of some questions of pathogenicity and immunity in dysentery using experimental models of Shigella keratoconjunctivitis in guinea pigs | Q77073432 | ||
| The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanisms | Q77179814 | ||
| Acquired natural immunity following recovery from keratoconjunctivitis shigellosa | Q78914365 | ||
| Involvement of RNA-binding protein Hfq in the post-transcriptional regulation of invE gene expression in Shigella sonnei | Q80399990 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| Editorial commentary: a Shigella vaccine against prevalent serotypes | Q88140060 | ||
| Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile | Q39252440 | ||
| Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactions | Q39461241 | ||
| Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis | Q40211202 | ||
| Supramolecular structure of the Shigella type III secretion machinery: the needle part is changeable in length and essential for delivery of effectors | Q40392389 | ||
| Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp. | Q41186719 | ||
| Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain | Q45892563 | ||
| Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh. | Q51745561 | ||
| A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. | Q54158784 | ||
| Development of a new guinea-pig model of shigellosis | Q57099015 | ||
| Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei | Q67941446 | ||
| Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati) | Q70422370 | ||
| Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials | Q70422374 | ||
| Hfq modulates the sigmaE-mediated envelope stress response and the sigma32-mediated cytoplasmic stress response in Escherichia coli | Q24680586 | ||
| Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells | Q27028058 | ||
| The versatility of Shigella effectors | Q28259971 | ||
| A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology | Q28767862 | ||
| A pediatric cluster of Shigella dysenteriae serotype 1 diarrhea with hemolytic uremic syndrome in 2 families from France | Q33360683 | ||
| Involvement of RNA-binding protein Hfq in the osmotic-response regulation of invE gene expression in Shigella sonnei | Q33454924 | ||
| The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells | Q33552436 | ||
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
| Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid | Q33828828 | ||
| Strategy for cross-protection among Shigella flexneri serotypes | Q34000330 | ||
| Shigella isolates from the global enteric multicenter study inform vaccine development | Q34202171 | ||
| The RNA-binding protein HF-I, known as a host factor for phage Qbeta RNA replication, is essential for rpoS translation in Escherichia coli | Q34383062 | ||
| RodZ regulates the post-transcriptional processing of the Shigella sonnei type III secretion system | Q35194777 | ||
| Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection | Q35221181 | ||
| Persistence of local cytokine production in shigellosis in acute and convalescent stages. | Q35380946 | ||
| Broadly protective Shigella vaccine based on type III secretion apparatus proteins | Q35805439 | ||
| Genetic analysis of an invasion region by use of a Tn3-lac transposon and identification of a second positive regulator gene, invE, for cell invasion of Shigella sonnei: significant homology of invE with ParB of plasmid P1 | Q36157790 | ||
| Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence. | Q36428530 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains | Q36989057 | ||
| Oral immunization of rabbits with enterotoxigenic Escherichia coli protects against intraintestinal challenge | Q36993634 | ||
| Identification of Shigella sonnei form I plasmid genes necessary for cell invasion and their conservation among Shigella species and enteroinvasive Escherichia coli | Q37026672 | ||
| The guinea pig as a model of infectious diseases. | Q37251175 | ||
| An update on vaccines against Shigella | Q37668395 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | RNA-binding proteins | Q3928341 |
| P304 | page(s) | e0005728 | |
| P577 | publication date | 2017-07-20 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype | |
| P478 | volume | 11 |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q92335399 | Enhancement of immune response against Bordetella spp. by disrupting immunomodulation |
| Q64099626 | Proteomics of intracellular Salmonella enterica reveals roles of Salmonella pathogenicity island 2 in metabolism and antioxidant defense |
| Q89695659 | Superstructure formation by RodZ hexamers of Shigella sonnei maintains the rod shape of bacilli |
Search more.